SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Healthcare District Dumps At-Large Elections

HEALTH: Grossmont Makes Move; Palomar Considers Election ChangeUnder the threat of a lawsuit from a Malibu attorney, one San Diego hospital district is moving to a new type of election system, while another will consider doing so.

Seven San Diego Companies went Public in 2018

San Diego saw seven IPOs in 2018, largely dominated by life sciences companies.

Neurocrine’s Tourette Syndrome Drug Misses Primary Goal

San Diego-based Neurocrine’s drug for Tourette syndrome failed to meet its primary goal in a mid-stage clinical trial, the company reported Dec. 12.

Following the Local Biotech VC Funding Trail

The San Diego Business Journal frequently chronicles local funding rounds and the big dreams that accompany them. But what about the largest venture capital sources locally?

House Bill Would Further Delay Medical Device Tax

Recently proposed legislation would further push back a 2.3 percent excise tax on medical device makers, San Diego’s ResMed, NuVasive and Ra Medical Systems among them.

Pfizer Move to Transfer 100 Jobs to San Diego

Pharmaceutical behemoth Pfizer is set to close a South San Francisco site and relocate 100 jobs to its research and development campus in La Jolla.

Report: Human Longevity’s Valuation Falls 80%

Human Longevity Inc.’s latest valuation: $310 million, down more than 80 percent from early 2017, according to the Wall Street Journal.

Oxeia Leading the Pack on Potential Concussion Treatments

Concentration Of Precision Health Companies

Precision health factors in a person’s genes, medical history, environment and more for diagnosis and treatment.

LunaDNA Launches Platform Giving Shares for DNA Data

LunaDNA’s first-of-its-kind platform giving shares for contributing DNA data got approval earlier this week from the U.S. Securities and Exchange Commission.

Ionis’ ALS Drug Candidate Nets $35M Payment from Biogen

Biogen exercised a licensing option and will pay Carlsbad’s Ionis Pharmaceuticals $35 million for a drug candidate aimed at amyotrophic lateral sclerosis, or ALS.

ViaCyte Gets $80M Series D For Pursuit of Diabetes Cure

ViaCyte recently hauled in an $80 million Series D round to advance therapies that the company called a potential “functional cure” for Type 1 diabetes patients.

Viracta Plots Entry Into China with $10M Financing and Partnership

San Diego-based Viracta Therapeutics intends to bring a cancer therapy candidate to China through a recently inked partnership with Chinese drug company Salubris

Court Narrows Use of Non-Solicitation Clause

LEGAL: AMN Loses Bid to Limit Ex-Recruiters’ Actions

A recent ruling involving competing health care staffing firms headquartered in San Diego makes it tougher for employers to restrict past employees from soliciting former clients.